Breakfast Masterclasses
Start the day right with an informative and energising Breakfast Session.
From 6.45am on Monday 10 October through to Wednesday 12 October you will have a choice of sessions exploring important issues in O&G delivered by Industry Experts. Breakfast Sessions are included in both day and full ASM Registration, as is the delicious breakfast that will be served during the session. Spots are limited and ticketed and are filling fast so secure your seat today.
Monday 10 October Masterclasses
Alcohol Advice in Obstetric Care
– By FARE
| Date: | Monday 10 October 2022 |
| Time: | 06.45 – 07.45 |
| Cost: | Free |
| Location: | Central Room C |
| Facilitators: | Vijay Roach (Immediate Past President, RANZCOG) |
| Presenters: | Angelene Bruce, Caterina Giorgi, CEO, Foundation for Alcohol Research and Education, and Colleen O'Leary |
The National Health and Medical Research Council’s Australian Guidelines to reduce health risks from drinking alcohol advise that ‘women who are pregnant or planning a pregnancy should not drink alcohol’. This guideline underpins the National Awareness Campaign for Pregnancy and Breastfeeding Women (the Campaign). In this panel discussion, we will explore the basis of the guideline and the approach of the campaign, which calls on health professionals to routinely assess for and provide advice about alcohol consumption during obstetric care.
The Business of O&G: Lessons Learnt
– By Ramsay Health Care
| Date: | Monday 10 October 2022 |
| Time: | 06.45 – 07.45 |
| Cost: | Free |
| Location: | Central Room A |
| Target Audience: | Trainees in final year of training, new Fellows |
| Presenters: | Rachel Green, St Andrew's Private Hospital, Ipswich; Sean Holland, Pindara Private Hospital, Gold Coast and Brad Robinson, Greenslopes Private Hospital, Greenslopes |
Are you curious about private practice? Unsure if it is for you? Or ready to get started! Come and hear the stories from a panel of O&G’s who have created successful private practices. They will share their diverse experience and the lessons they have learnt along the journey. And you can ask them questions, and get answers to inform your decision making.
How to Get Started in Research
– By RANZCOG
| Date: | Monday 10 October 2022 |
| Time: | 06.45 – 07.45 |
| Cost: | Free |
| Location: | Central Room B |
| Target Audience: | Novice to experienced career researchers are welcome, as well as any general fans of evidence based medicine. |
| Presenters: | Nancy Chescheir, MD, Caroline Homer, et al |
With a superstar line-up of established leading researchers, this panel will keep you engaged and entertained over breakfast and coffee before we launch into Day 1 of the ASM Program. Our team of senior researchers will talk about how to jump into research: finding the right topics and supervisor, establishing a research footprint without funding. For early and mid-career researchers we will discuss creating an agenda of work, building multidisciplinary research projects and teams as well as tips and tricks for publishing success and grant writing. The session will focus on ways to create and maintain both local international collaborations, with an opportunity to meet and network with other researchers from home and abroad. Finally, our experienced panel will delve into finding their jam in academic leadership with a discussion of the key advantages and challenges in combining a clinical and academic career.
Tuesday 11 October Masterclasses
Patient Complaints Process: How to Manage
– By Avant Mutual Group
| Date: | Tuesday 11 October |
| Time: | 07.00 – 08.00 |
| Cost: | Free |
| Location: | Central Room B |
| Presenters: | Marianna Kelly, Risk Adviser, Avant (Host), Tal Jacobson, Elizabeth Quinn, Senior Associate, Professional Conduct, Avant and Michael Wright, CMO, Avant |
Avant is a mutual not-for-profit organisation, which supports more than 78,000 Australian health professionals. With more members, more medical-legal expertise and more claims experience as well as the largest in-house legal team of any Australian medical defence organisation, Avant is uniquely placed to help medical professionals keep abreast of developments in medico-legal risk.
This session will consist of a panel of Avant and RANZCOG experts who discuss their experiences with a complaint entity (AHPRA, OHO, HCCC) process. Each member of the panel will present for 10 mins followed by a Q&A session.
Reproductive Carrier Screening:
Making it Work in Your Practice
– By Sonic Genetics
| Date: | Tuesday 11 October 2022 |
| Time: | 07.00 – 08.00 |
| Cost: | Free |
| Location: | Central Room A |
| Presenters: | Marina Berbic and Belinda Dopita |
Sonic Genetics is the genetic testing arm of Sonic Healthcare Australia and provides reproductive carrier screening (RCS) through the eight practices that make up Sonic’s pathology division in Australia. RCS is a mainstream test. RANZCOG guidelines state that any practitioner providing reproductive care should offer information about carrier screening to women who are planning a pregnancy or who are in early pregnancy. The merit of this requirement is not in dispute. The challenge lies in providing information about the purpose, scope, cost and outcomes of different carrier screening options to meet this professional obligation in the context of a busy practice.
The growing complexity of genetic testing can overload both the provider and the recipient of this information. This Masterclass will identify the key objectives that must be met for the responsible provision of carrier screening and, by providing easy-access resources, assist clinicians in meeting these objectives. The format of the Masterclass will be a panel discuss, which will address the information and counselling objectives related to RCS, discuss currently available resources, and introduce a new online course for patients that will help practitioners meet their professional and ethical obligations regarding RCS.
The Role of Angiogenic Markers
in Prenatal Screening and
Diagnosis: PlGF and sFlt in the
First and Third Trimester of Pregnancy
– By Roche Diagnostics
| Date: | Tuesday 11 October 2022 |
| Time: | 07.00 – 08.00 |
| Cost: | Free |
| Location: | Central Room C |
| Presenters: | Fabricio Silva da Costa and Jon Hyett |
Angiogenic markers associated with placental function (PlGF and sFlt) are becoming more widely available for both prediction / prevention and diagnosis / management of preeclampsia and fetal growth restriction. In this session, Professor Silva da Costa and Professor Hyett will detail the research that supports population-based screening for early onset preeclampsia and the benefit of using these markers in the second and third trimester to demonstrate disease severity in women deemed to have symptoms / signs of either preeclampsia or IUGR.
Roche Diagnostics is committed to Women’s Health. Our innovative solutions give clinicians the ability to provide the right treatment at the right time, offering a confidence to the patients they treat, that only Roche Diagnostics can deliver. By addressing high burden conditions and diseases unique to women in pregnancy care, fertility, bone health and cervical cancer, the Roche tests enable clinicians to individualise a woman’s care and reduce the risk of over or under treatment. Roche Diagnostics is proud to sponsor this breakfast session to help demonstrate the value that pre-eclampsia biomarker testing can provide to clinicians and their patients
in Australia.
Wednesday 12 October Masterclasses
Intrauterine Systems – the Place in Therapy from Adolescence to Menopause. Does Size Matter?
- By Bayer
| Date: | Wednesday 12 October 2022 |
| Time: | 07.15 – 08.15 |
| Cost: | Free |
| Location: | Exhibition Floor |
| Presenters: | Meredith Frearson & Katherine Whitton |
This Masterclass will be with held at Bayer's stand in the Trade Exhibition Hall.
View the Program Overview here.
After 20+ years of Mirena in Australia and 2 years since launch for Kyleena, what has been the Australian experience. Has Kyleena found its place in expanding LARC use in the nulliparous woman.
Real-world evidence from KYSS (the Kyleena Satisfaction Study) in support.
With the opportunity to experience the haptic, high-fidelity Pelvic SIM, offering procedural practice in the training setting, with case scenarios that provide real-time feedback on device placement and patient comfort.
What’s Next in Contraception
- By Mayne Pharma
| Date: | Wednesday 12 October 2022 |
| Time: | 07.15 – 08.15 |
| Cost: | Free |
| Location: | Central Room C |
| Facilitators: | Prescribing clinicians and registrars specialising in contraception, but also for OBGYNs for general knowledge of newly approved COC containing a new estrogen. |
| Presenters: | International Speaker, Mitchell Creinin in conversation with Deborah Bateson |
It’s been 60 years since the introduction of the contraceptive pill in Australia. In 1965, estetrol (E4), a natural estrogen produced during pregnancy, was discovered. After extensive research, in 2021, NEXTSTELLIS containing E4 was approved for use in Europe, North America and recently Australia. NEXTSTELLIS is the first and only contraceptive pill containing E4, now derived from a plant source and combined with drospirenone. E4 is considered to be a low impact estrogen due to its unique structure and selective tissue action. E4 has an affinity for both estrogen and alpha and beta receptors, with a strong preference for the alpha receptor. E4 only activates the nuclear receptor and blocks membrane receptor activation. This selective activation is the basis for E4’s variable impact throughout the body.
As this is a new estrogen in the combined oral contraceptive pill, it’s important to understand the science behind E4 and what clinical outcomes we expect to see. In this masterclass, we will present the latest data on E4, including the environmental impact of E4 on selected aquatic organisms and show how it behaves differently in a woman’s body to other estrogens used in the contraceptive pill.
Is There a Need for National Guidelines on Iron Deficiency in Women’s Health in Australia/NZ?
- By CSL Vifor
| Date: | Wednesday 12 October 2022 |
| Time: | 07.15 – 08.15 |
| Cost: | Free |
| Location: | Central Room A |
| Presenters: | Elizabeth Farrell AM and Lisa Clarke |
Iron deficiency is the most prevalent nutritional deficiency worldwide. Iron deficiency anaemia affects approximately 20% of the world’s population and iron deficiency without anaemia is even more common. It is an important public health problem in Australia. The World Health Organization (WHO) estimates that 8% of preschool children, 12% of pregnant women and 15% of non-pregnant women of reproductive age in Australia have anaemia, with iron deficiency being the major cause. Although it is three times as common as iron deficiency anaemia, iron deficiency without anaemia is an under-recognised and undertreated condition.
The lack of consistent national guidelines poses a challenge in how iron deficiency is managed in women.
Join two experts who will discuss the pros and cons of developing a national consensus on Iron Deficiency.
Transition to Retirement
- By RANZCOG Transition to Retirement Working Group
| Date: | Wednesday 12 October 2022 |
| Time: | 07.15 – 08.15 |
| Cost: | Free |
| Location: | Central Room B |
| Presenters: | Sue Fleming (Facilitator), Tony Geraghty, Peter Henderson, Monique Doney (Financial Advisor -Perpetual Limited), Sharee Johnson (Psychologist Coach) |
Discussions between members of the College and a study undertaken by Dr Rupert Sherwood have identified that there are currently limited resources to support Fellows who are planning to transition into retirement. In 2021, The RANZCOG Board approved the creation of the Transition to Retirement Working Group to develop resources and strategies in this area. The transition process can be challenging, and it is important for the College to support our members in planning for their retirement well before it occurs. The group aims to educate members on how best to prepare and transition to retirement from multiple perspectives and develop a suite of resources to support members through this journey.
The aim of this session is to provide an overview of psychological and emotional aspects of Transitioning to Retirement as well as financial and medico legal considerations. Participants will hear from a clinical psychologist, a Medico Legal Representative (to discuss financial and legal considerations) and a RANZCOG expert. This will be followed by a Q&A session.
At the end of this educational session, participants will be able to:
- Identify the challenges associated with transitioning to retirement and the benefits of preparing early
- Develop personal financial and emotional objectives for a smooth transition to retirement
- Begin developing a transition to retirement plan
